Resumen
The first enantioselective total synthesis of griseusin A, griseusin C, 4′-deacetyl-griseusin A, and two non-native counterparts in 11–14 steps is reported. This strategy highlights a key hydroxy-directed CH olefination of 1-methylene isochroman with an α,β-unsaturated ketone followed by subsequent stereoselective epoxidation and regioselective cyclization to afford the signature tetrahydro-spiropyran ring. Colorectal cancer cell cytotoxicities of the final products highlight the impact of the griseusin tetrahydro-spiropyran ring on bioactivity. As the first divergent enantioselective synthesis, the strategy put forth sets the stage for further griseusin mechanism-of-action and SAR studies.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 11219-11222 |
| Número de páginas | 4 |
| Publicación | Angewandte Chemie - International Edition |
| Volumen | 54 |
| N.º | 38 |
| DOI | |
| Estado | Published - sept 14 2015 |
Nota bibliográfica
Publisher Copyright:© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Financiación
This work was supported, in part, by the University of Kentucky College of Pharmacy, the University of Kentucky Markey Cancer Center, National Institutes of Health grant CA175105 (Q.‐B. She), and the National Center for Advancing Translational Sciences (UL1TR000117).
| Financiadores | Número del financiador |
|---|---|
| University of Kentucky | |
| National Institutes of Health (NIH) | CA175105 |
| National Center for Advancing Translational Sciences (NCATS) | UL1TR000117, KL2TR000116 |
| University of Kentucky Markey Cancer Center |
ASJC Scopus subject areas
- Catalysis
- General Chemistry